Normocin® - Antimicrobial Reagent

Protection against mycoplasma, bacteria and fungi

Normocin® is an innovative antibiotic formulation designed to prevent cell lines from mycoplasma, bacterial and fungal contaminations.
Normocin® can be routinely added in the cell culture medium in combination with Penicillin/Streptomycin to broaden the anti-bacterial spectrum.

Key Features:

• Active against both Gram+ and Gram- bacteria, mycoplasmas and fungi
• Can be used in combination with Penicillin/Streptomycin
• Non-toxic to the cell line being treated

Normocin® contains three compounds. Two of these compounds act on Gram+ bacteria, Gram- bacteria, and mycoplasmas by blocking DNA and protein synthesis. The third compound eradicates yeasts and fungi by disrupting ionic exchange through the cell membrane.

Note: Normocin® is a trademark of InvivoGen registered with the United States Patent and Trademark Office and foreign equivalents.

All InvivoGen products are for internal research use only, and not for human or veterinary use.

Figures

Specifications

Product concentration: 50 mg/ml

Active concentration not toxic for treated cell lines: 100 μg/ml

One 1 ml vial of Normocin® is sufficient to treat 500 ml of culture.
One 20 ml bottle of Normocin® is sufficient to treat 10 liters of culture.

Physicochemical characterization: pH and appearance

Endotoxin level: < 0.5 EU/mg

Cell culture tested: potency validated on bacterial and fungal reference strains

Contents

Normocin® is provided as a cell culture tested, sterile filtered, red solution at a concentration of 50 mg/ml.

This product is available in three pack sizes:

• ant-nr-05:  5 x 1 ml vial (250 mg)
• ant-nr-1:  10 x 1 ml vial (500 mg)
• ant-nr-2:  1 x 20 ml bottle (1 g) 

Normocin® is shipped at room temperature.

Upon receipt it should be stored at 4°C or -20°C.